From solo primary care physicians to multi-specialty groups: how medical practices are valued, financed, and acquired in a landscape shaped by MSOs, PE rollups, and hospital employment. The rules differ dramatically by specialty, payor mix, and scale.

4-8xEBITDA multiple

$500K-$20MTransaction range

SBA+Conv.Primary financing

120-180dAvg. close

Benchmark reference

EBITDA margin (target)18-28%

Staff expense %24-30%

Medical supplies %4-8%

Collection rate93-97%

Revenue per provider$350-700K

AR days (target)30-45 days

Payor mix (commercial)40-65%

DSCR minimum1.25x

Practice Overview & Market Context

Overview

Medical practice M&A is undergoing structural transformation. MSOs (Management Services Organizations) backed by private equity have emerged as the dominant buyer in specialties like dermatology, gastroenterology, urology, cardiology, and orthopedics. Meanwhile, hospital systems continue to employ physicians at scale, and independent group practices are merging to gain negotiating power with payors. The result is a bifurcated market: PE-backed MSOs paying premium multiples for scalable specialty groups, and SBA-financed individual physicians acquiring primary care practices.

Payor mix is the single most important variable in medical practice valuation. A dermatology practice with 60% commercial PPO and 40% cash-pay cosmetic revenue at 28% EBITDA margins is worth dramatically more than an identical-revenue family medicine practice with 40% Medicaid and 30% Medicare. Everything else -- scale, growth, transferability -- matters, but payor mix is the foundation.

Value accelerators

Commercial / cash-pay dominant mix -- 50%+ commercial PPO or cash-pay procedures maximizes realized revenue per encounter

Ancillary services -- in-office lab, imaging, infusion, surgical center dramatically increase revenue per patient

Multi-provider group -- 3+ physicians reduce key-person risk and signal operational scalability

Specialty premium -- dermatology, GI, urology, cardiology, ortho command higher multiples than primary care

Established referral network -- documented specialist relationships create defensible patient flow

Clean collections / low AR days -- AR days under 40 and collection rate above 95% signal strong billing operations

Value discounts

Medicaid / Medicare heavy mix -- below-market reimbursement rates compress margins and limit buyer pool to MSOs with cost-reduction expertise

Single-physician dependency -- if the selling physician generates 80%+ of collections, buyer faces key-person risk

Credentialing gaps -- payor credentialing takes 90-180 days; gaps create post-close revenue disruption

Aging EHR / billing systems -- legacy systems require costly migration that buyers factor into price

Regulatory exposure -- Stark Law, HIPAA violations, or coding audits represent tail liabilities

📋

MSO vs. direct acquisition -- the two models

MSO acquisitions involve the practice selling its business assets and entering a long-term management services agreement. The physician retains the professional entity (PC or PLLC) as required by corporate practice of medicine (CPOM) laws in most states. In an MSO deal, you are selling the management company, not the medical practice itself. The physician continues to own the clinical entity -- the MSO owns everything else. This legal distinction is critical for Stark Law compliance and state licensing.

Medical PracticeFinancing & Valuation

Practice Overview & Market Context

Medical Practice
Financing & Valuation